IRIS
MANZIA, TOMMASO MARIA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 19.416
EU - Europa 1.539
AS - Asia 1.530
SA - Sud America 15
Continente sconosciuto - Info sul continente non disponibili 9
OC - Oceania 8
AF - Africa 4
Totale 22.521
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 19.402
SG - Singapore 765
CN - Cina 373
IT - Italia 282
DE - Germania 247
IE - Irlanda 247
UA - Ucraina 196
RU - Federazione Russa 193
HK - Hong Kong 178
GB - Regno Unito 125
KR - Corea 102
FI - Finlandia 58
SE - Svezia 51
FR - Francia 38
ID - Indonesia 26
NL - Olanda 25
IN - India 24
VN - Vietnam 17
BE - Belgio 16
CZ - Repubblica Ceca 14
CA - Canada 13
BR - Brasile 11
TR - Turchia 11
JP - Giappone 9
AT - Austria 7
EU - Europa 7
GR - Grecia 7
AU - Australia 6
ES - Italia 6
CH - Svizzera 5
PL - Polonia 5
EG - Egitto 4
TM - Turkmenistan 4
CO - Colombia 3
HR - Croazia 3
IL - Israele 3
IQ - Iraq 3
PT - Portogallo 3
HU - Ungheria 2
IR - Iran 2
KH - Cambogia 2
LT - Lituania 2
MY - Malesia 2
NZ - Nuova Zelanda 2
A1 - Anonimo 1
A2 - ???statistics.table.value.countryCode.A2??? 1
AE - Emirati Arabi Uniti 1
AL - Albania 1
AZ - Azerbaigian 1
DK - Danimarca 1
DM - Dominica 1
EC - Ecuador 1
EE - Estonia 1
JO - Giordania 1
KG - Kirghizistan 1
KW - Kuwait 1
KZ - Kazakistan 1
LV - Lettonia 1
MD - Moldavia 1
MV - Maldive 1
NO - Norvegia 1
PH - Filippine 1
RO - Romania 1
TW - Taiwan 1
Totale 22.521
Salva come PNG Salva come JPEG
Città #
Wilmington 5.354
Houston 4.909
Woodbridge 4.298
Fairfield 796
Singapore 682
Ann Arbor 472
Chandler 460
Ashburn 341
Seattle 306
Cambridge 287
Dublin 236
Santa Clara 191
Medford 184
Hong Kong 174
Jacksonville 168
Beijing 124
New York 114
Zhengzhou 101
Rome 95
Lawrence 86
Dearborn 73
Council Bluffs 52
San Diego 50
Creede 45
Moscow 45
Menlo Park 34
Mülheim 28
London 26
Jakarta 25
Milan 24
Palo Alto 24
Los Angeles 23
Shanghai 22
Nanjing 20
Mountain View 18
Boardman 17
Redwood City 17
Munich 16
Norwalk 16
Brussels 15
Helsinki 15
Seoul 15
Dong Ket 14
Hefei 13
Toronto 13
Engelhard 12
Hounslow 9
Olomouc 9
Amsterdam 8
Guangzhou 8
Islington 8
Saint Petersburg 8
University Park 8
Aydin 7
Kunming 7
Nanchang 7
Nürnberg 7
San Mateo 7
Verona 7
Civita Castellana 6
Colorado Springs 6
Falls Church 6
Genoa 6
Lappeenranta 6
New Bedfont 6
Pune 6
São Paulo 6
Turin 6
Vienna 6
Brno 5
Chicago 5
Miami 5
Shenyang 5
Washington 5
Athens 4
Chiswick 4
Frankfurt am Main 4
Viareggio 4
Yinchuan 4
Delhi 3
Detroit 3
Eschweiler 3
Esslingen am Neckar 3
Gdynia 3
Hangzhou 3
Hebei 3
Jinan 3
Kilburn 3
Nuremberg 3
Phoenix 3
Qingdao 3
Sydney 3
Thessaloniki 3
Wuhan 3
Xian 3
Zagreb 3
Asaka 2
Augusta 2
Basra 2
Bhubaneswar 2
Totale 20.314
Salva come PNG Salva come JPEG
Nome #
Re-Evaluation of the Role of Antifibrinolytic Therapy with Lysine Analogs in Liver Transplantation in The Post-Aprotinin Era 457
HCV-RNA quantification in liver bioptic samples and extrahepatic compartments, using the abbott RealTime HCV assay 448
Impact of immunosuppression minimization and withdrawal in long-term hepatitis C virus liver transplant recipients 445
Primary yolk sac tumor of the liver: incidental finding in a patient transplanted for hepatocellular carcinoma 439
Relationship between GH/IGF-1 Axis, graft recovery, and early survival in patients undergoing liver transplantation 436
Glycogen storage disease type Ia and VI associated with hepatocellular carcinoma: Two case reports 436
Deep vein thrombosis as debut of cytomegalovirus infection associated with type ii cryoglobulinemia, with antierythrocyte specificity in a kidney transplant recipient: A case report 435
Hepatitis C virus recurrence and immunosuppression-free state after liver transplantation. 427
Complete weaning off immunosuppression in HCV liver transplant recipients is feasible and favourably impacts on the progression of disease recurrence. 423
Steroid-free immunosuppression after liver transplantation does not increase the risk of graft fibrosis. 421
Marginal donors in liver transplantation. 419
Amantadine monotherapy is ineffective in the treatment of hepatitis C virus recurrence in the post-liver transplantation setting. 413
Liver abscess caused by foreign body ingestion 409
Management of spermatic cord liposarcoma in renal transplant recipients: case report 406
596 406
Combined liver transplantation and sleeve gastrectomy for end-stage liver disease in a bariatric patient: First European case-report 405
Use of mycophenolate mofetil in liver transplantation: a literature review. 400
Complete hbv prophylaxis withdrawal in HBsAg-positive liver transplant recipients after long-term minimal immunosuppression 397
Ab initio calcineurin inhibitor-based monotherapy immunosuppression after liver transplantation reduces the risk for Pneumocystis jirovecii pneumonia. 396
Intra-graft expression of genes involved in iron homeostasis predicts the development of operational tolerance in human liver transplantation. 391
Long-term, maintenance MMF monotherapy improves the fibrosis progression in liver transplant recipients with recurrent hepatitis C 390
The Tor Vergata weaning of immunosuppression protocols in stable hepatitis C virus liver transplant patients: the 10-year follow-up 385
Liver transplantation in primary hepatic carcinoid tumor: case report and literature review. 384
Surgical antibiotic prophylaxis after renal transplantation: time to reconsider. 382
Side-to-side caval anastomosis in a patient receiving a liver graft from a marginal donor with situs inversus totalis 381
Amantadine monotherapy is ineffective in the treatment of hepatitis C virus recurrence in the post-liver transplantation setting 380
Liver transplantation for the treatment of nodular regenerative hyperplasia 379
Different expression of VEGF and EGFL7 in human hepatocellular carcinoma 374
Immunosuppression-Free Liver Transplantation 370
Radiofrequency-assisted right hemihepatectomy by using a new incremental bipolar generator combined with liver hanging maneuver. 363
One-shot versus multidose perioperative antibiotic prophylaxis after kidney transplantation: A randomized, controlled clinical trial 361
Prospect for kidney bioengineering: Shortcomings of the status quo 353
The Tor Vergata weaning off immunosuppression protocol in stable HCV liver transplant patients: the updated follow up at 78 months. 349
Myopericytoma of the Liver Hilus: A Case Report 342
Switch from twice-daily tacrolimus (Prograf) to once-daily prolonged-release tacrolimus (Advagraf) in kidney transplantation. 338
Liver transplantation for hepatitis B and C virus-related cirrhosis: mid-term results 321
Successful management of a same-day emergency delivery and liver transplant in a 27 weeks pregnant woman with fulminant hepatic failure. 318
Combined liver transplantation and sleeve gastrectomy for end-stage liver disease in a bariatric patient: First European case-report 317
Ab initio Everolimus-based Versus Standard Calcineurin Inhibitor Immunosuppression Regimen in Liver Transplant Recipients 305
Clinical Operational Tolerance and Immunosuppression Minimization in Kidney Transplantation: Where Do We Stand? 284
Donation after circulatory death in paediatric liver transplantation: current status and future perspectives in the machine perfusion era 283
An unusual duodenal polyp causing anemia in a liver-transplanted patient 282
Impact of remnant vital tissue after locoregional treatment and liver transplant in hepatocellular cancer patients, a multicentre cohort study 269
Pitfalls in the reporting of upper endoscopy features in cirrhotic patients 261
Liver transplantation with a normothermic machine preserved fatty nonagenarian liver: A case report 257
Direct-acting antivirals and hepatocellular carcinoma in chronic hepatitis C: A few lights and many shadows 249
Longterm Survival and Cost-Effectiveness of Immunosuppression Withdrawal After Liver Transplantation 244
Recurrence of hepatocellular carcinoma after direct acting antiviral treatment for hepatitis C virus infection: Literature review and risk analysis 232
Effect of direct-acting antivirals on future occurrence of hepatocellular carcinoma in compensated cirrhotic patients 230
Rare malignant glomus tumor of the stomach with liver metastases 210
Pandora’s Box: Unpredictable Evolution of a 20-Year History of a Bariatric Patient—Report of Small Bowel Migrated Gastric Band after Redo Banded Gastric Bypass 209
HCV resistance compartmentalization within tumoral and non-tumoral liver in transplanted patients with hepatocellular carcinoma 188
Everolimus and enteric-coated mycophenolate sodium Ab initio after liver transplantation: Midterm results 171
Platelets and hepatocellular cancer: Bridging the bench to the clinics 168
Intention-to-treat survival benefit of liver transplantation in patients with hepatocellular cancer 165
Liver transplantation for hepatocellular carcinoma: Where do we stand? 161
The COVID-19 outbreak in Italy: initial implications for organ transplantation programs 153
Switch From Twice-daily Tacrolimus to Once-daily, Prolonged-release Tacrolimus in Kidney Transplantation: Long-term Outcome 151
Everolimus and Advagraf Ab Initio in Combined Liver and Kidney Transplant With Donor-Specific Antibodies: A Case Report 150
De novo malignancies after liver transplantation: The effect of immunosuppression-personal data and review of literature 146
Vascular anomalies of the celiac trunk and implications in treatment of HCC with TACE. Description of a case and review of the literature 145
Liver transplantation in a patient with complete portal vein thrombosis, is there a surgical way out? A case report 142
Evaluation of Contrast-Enhanced Intraoperative Ultrasound in the Detection and Management of Liver Lesions in Patients with Hepatocellular Carcinoma 133
Abdominal organ bioengineering: current status and future perspectives 131
Using a weaning immunosuppression protocol in liver transplantation recipients with hepatocellular carcinoma: A compromise between the risk of recurrence and the risk of rejection? 129
How do synchronous lung metastases influence the surgical management of children with hepatoblastoma? An update and systematic review of the literature 127
The Intention-to-Treat Effect of Bridging Treatments in the Setting of Milan Criteria–In Patients Waiting for Liver Transplantation 116
Laparoscopic adrenalectomy for hemorrahagic adrenal pseudocyst discovered during pregnancy: Report of a case 111
Screening of Fabry Disease of patients in renal replacement therapy in a population from Lazio (Italy) 107
Combined liver transplantation and sleeve gastrectomy for end-stage liver disease in a bariatric patient: First European case-report 104
Serum Levels of Granulocyte-Macrophage-colony-stimulating Factor and Stem-cell Factor During Liver Regeneration after Partial Hepatectomy in Humans 86
Hepatitis B virus recurrence after liver transplantation: An old tale or a clear and present danger? 79
Current strategies to minimize ischemia-reperfusion injury in liver transplantation: a systematic review 58
null 55
Graft weight integration in the early allograft dysfunction formula improves the prediction of early graft loss after liver transplantation 53
null 51
“Salus Populi Suprema Lex”: Considerations on the Initial Response of the United Kingdom to the SARS-CoV-2 Pandemic 45
Elective surgery system strengthening: development, measurement, and validation of the surgical preparedness index across 1632 hospitals in 119 countries 44
null 42
null 41
The role of antiplatelet therapies on incidence and mortality of hepatocellular carcinoma 41
null 40
null 40
Correction to: Immunosuppressive regimens for adult liver transplant recipients in real-life practice: consensus recommendations from an Italian Working Group (Hepatology International, (2020), 14, 6, (930-943), 10.1007/s12072-020-10091-5) 39
Temporal trends of waitlistings for liver transplantation in Italy: the ECALITA (Evolution of IndiCAtion in LIver transplantation in ITAly) registry study 38
Successful clinical and virological outcomes of liver transplantation for HDV/HBV-related disease after long-term discontinuation of hepatitis B immunoglobulins 36
null 35
null 35
Successful pregnancy in a living-related kidney transplant recipient who received sirolimus throughout the whole gestation 34
Urological Complications in Kidney Transplant Recipients: Analysis of the Risk Factors and Impact on Transplant Outcomes in the Era of “Extended Criteria Donors” 32
null 30
null 30
null 30
Evaluation of Humoral Response following SARS-CoV-2 mRNA-Based Vaccination in Liver Transplant Recipients Receiving Tailored Immunosuppressive Therapy 30
null 30
null 29
null 29
The efficacy and safety of mammalian target of rapamycin inhibitors ab initio after liver transplantation without corticosteroids or induction therapy 29
Overview of prognostic systems for hepatocellular carcinoma and ITA.LI.CA external validation of MESH and CNLC classifications 29
Successful treatment of systemic de novo sarcoidosis with cyclosporine discontinuation and provision of rapamune after liver transplantation 28
Totale 22.127
Salva come PNG Salva come JPEG
Categoria #
all - tutte 64.066
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 64.066
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20203.197 0 0 0 0 0 0 552 491 630 575 437 512
2020/20214.039 472 487 459 484 391 458 473 454 78 125 95 63
2021/2022933 54 90 16 32 24 95 61 33 123 117 54 234
2022/20231.406 141 123 15 151 112 259 109 251 105 12 93 35
2023/2024685 77 37 81 16 95 162 32 13 20 38 9 105
2024/20251.999 96 767 452 239 43 401 1 0 0 0 0 0
Totale 23.105